A Facile, Transfection-Free Approach to siRNA Delivery in In Vitro 3D Spheroid Models

被引:0
|
作者
Riching, Andrew S. [1 ]
Malloy, Allyson [1 ]
Anderson, Emily M. [1 ]
Sheard, Jonathan [2 ]
Mikkonen, Piia [2 ]
Smith, Anja van Brabant [1 ]
Strezoska, Zaklina [1 ]
Levenga, Josien [1 ]
机构
[1] Revvity Inc, Lafayette, CO 80026 USA
[2] UPM Kymmene Corp, Helsinki, Finland
来源
CURRENT PROTOCOLS | 2024年 / 4卷 / 09期
关键词
3D spheroids; extracellular matrix; gene function; RNA interference; PROTEIN; STRESS; CANCER; CELLS; ACTIVATION; EXPRESSION;
D O I
10.1002/cpz1.1121
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Cell culture has long been essential for preclinical modeling of human development and disease. However, conventional two-dimensional (2D) cell culture fails to faithfully model the complexity found in vivo, and novel drug candidates that show promising results in 2D models often do not translate to the clinic. More recently, three-dimensional (3D) cell culture models have gained popularity owing to their greater physiological relevance to in vivo biology. In particular, 3D spheroid models are becoming widely used due to their ability to mimic solid tumors, both in architecture and gradation of nutrients distributed from the outer, proliferative layers into the inner, quiescent layers of cells. Similar to in vivo tumors, cell lines grown in 3D spheroid models tend to be more resistant to antitumor drug treatments than their 2D cultured counterparts, though distinct signaling pathways and gene targets conferring this resistance have yet to be fully explored. RNA interference (RNAi) is an effective tool to elucidate gene function and discover novel druggable targets in 2D models; however, only a few studies have successfully performed RNAi in complex 3D models to date. Here, we demonstrate efficient RNAi-mediated knockdown using "transfection-free" Dharmacon Accell siRNAs in three spheroid culture models, in the presence or absence of the extracellular matrix. This methodology has the potential to be scaled up for complex arrayed screening experiments, which may aid in the identification of novel druggable targets with greater clinical relevance than those identified in 2D experiments. (c) 2024 Dharmacon, Inc. Current Protocols published by Wiley Periodicals LLC.Basic Protocol 1: Generation of 3D spheroids in matrix-free ULA platesAlternate Protocol 1: Generation of Matrigel matrix-embedded 3D spheroidsAlternate Protocol 2: Generation of GrowDex hydrogel-embedded 3D spheroidsBasic Protocol 2: Delivery of siRNA and collection of matrix-free 3D spheroidsAlternate Protocol 3: Delivery of siRNA and collection of matrix-embedded spheroidsBasic Protocol 3: RNA and protein extraction from spheroids for characterization of gene knockdown
引用
收藏
页数:24
相关论文
共 50 条
  • [31] 3D in vitro cancerous tumor models: Using 3D printers
    Zahedi-Tabar, Zahra
    Bagheri-Khoulenjani, Shadab
    Mirzadeh, Hamid
    Amanpour, Saeid
    MEDICAL HYPOTHESES, 2019, 124 : 91 - 94
  • [32] Hepatic 3D spheroid models for the detection and study of compounds with cholestatic liability
    Hendriks, Delilah F. G.
    Puigvert, Lisa Fredriksson
    Messner, Simon
    Mortiz, Wolfgang
    Ingelman-Sundberg, Magnus
    SCIENTIFIC REPORTS, 2016, 6
  • [33] Multicellular tumor spheroid models to explore cell cycle checkpoints in 3D
    Jennifer Laurent
    Céline Frongia
    Martine Cazales
    Odile Mondesert
    Bernard Ducommun
    Valérie Lobjois
    BMC Cancer, 13
  • [34] 3D in vitro models of human blastocysts
    Madhura Mukhopadhyay
    Nature Methods, 2021, 18 : 445 - 445
  • [35] 3D PROSTATE CANCER IN VITRO MODELS
    Alhusaini, Khalsa
    Tirella, Annalisa
    Domingos, Marco
    Nicolaou, Anna
    TISSUE ENGINEERING PART A, 2023, 29 (11-12) : 935 - 936
  • [36] 3D in vitro models of human blastocysts
    Mukhopadhyay, Madhura
    NATURE METHODS, 2021, 18 (05) : 445 - 445
  • [37] 3D in vitro models of liver fibrosis
    van Grunsven, Leo A.
    ADVANCED DRUG DELIVERY REVIEWS, 2017, 121 : 133 - 146
  • [38] Multicellular tumor spheroid models to explore cell cycle checkpoints in 3D
    Laurent, Jennifer
    Frongia, Celine
    Cazales, Martine
    Mondesert, Odile
    Ducommun, Bernard
    Lobjois, Valerie
    BMC CANCER, 2013, 13
  • [39] Hepatic 3D spheroid models for the detection and study of compounds with cholestatic liability
    Delilah F. G. Hendriks
    Lisa Fredriksson Puigvert
    Simon Messner
    Wolfgang Mortiz
    Magnus Ingelman-Sundberg
    Scientific Reports, 6
  • [40] 3D hepatic spheroid models for the detection and study of compounds with cholestatic liability
    Hendriks, D. F.
    Puigvert, L. Fredriksson
    Messner, S.
    Moritz, W.
    Sundberg, M. Ingelman
    TOXICOLOGY LETTERS, 2016, 258 : S134 - S135